Milestone Scientific (NYSE:MLSS) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note published on Tuesday. The brokerage issued a hold rating on the stock.

Separately, Benchmark reissued a “speculative buy” rating and issued a $1.25 price target on shares of Milestone Scientific in a report on Wednesday, November 20th.

Milestone Scientific Stock Down 1.0 %

Shares of MLSS stock opened at $1.01 on Tuesday. Milestone Scientific has a 12 month low of $0.52 and a 12 month high of $1.10. The firm has a market cap of $78.67 million, a PE ratio of -14.43 and a beta of 1.08. The stock has a 50 day moving average of $0.83 and a 200-day moving average of $0.85.

Insider Transactions at Milestone Scientific

In other Milestone Scientific news, Director Leonard Osser sold 107,984 shares of the business’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total value of $100,425.12. Following the completion of the transaction, the director now directly owns 4,606,882 shares of the company’s stock, valued at approximately $4,284,400.26. The trade was a 2.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Over the last 90 days, insiders sold 109,193 shares of company stock valued at $101,634. Corporate insiders own 24.75% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of MLSS. Y Intercept Hong Kong Ltd acquired a new position in shares of Milestone Scientific in the 3rd quarter valued at $48,000. World Investment Advisors LLC bought a new position in shares of Milestone Scientific during the 3rd quarter valued at about $91,000. Finally, Geode Capital Management LLC lifted its stake in Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after buying an additional 31,572 shares in the last quarter. 5.79% of the stock is currently owned by institutional investors.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.